BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25148281)

  • 1. Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema.
    Ito E; Muro Y; Shibata A; Sugiura K; Akiyama M
    Dermatol Online J; 2014 Aug; 20(8):. PubMed ID: 25148281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatomyositis-like eruption after long-term hydroxyurea therapy for polycythemia vera.
    Oskay T; Kutluay L; Ozyilkan O
    Eur J Dermatol; 2002; 12(6):586-8. PubMed ID: 12459535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatomyositis-like eruption induced by hydroxyurea: a case report.
    Janerowicz D; Czarnecka-Operacz M; Stawny M; Silny W
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Sep; 18(3):131-4. PubMed ID: 19784527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption?
    Nofal A; El-Din ES
    Int J Dermatol; 2012 May; 51(5):535-41. PubMed ID: 22515579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
    Olesen LH; Pedersen BB
    Ugeskr Laeger; 2001 Dec; 163(49):6908-11. PubMed ID: 11766504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea-induced dermatomyositis-like eruption.
    Senet P; Aractingi S; Porneuf M; Perrin P; Duterque M
    Br J Dermatol; 1995 Sep; 133(3):455-9. PubMed ID: 8547004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous ulcers associated with hydroxyurea therapy in myeloproliferative disorders.
    Ravandi-Kashani F; Cortes J; Cohen P; Talpaz M; O'Brien S; Markowitz A; Kantarjian H
    Leuk Lymphoma; 1999 Sep; 35(1-2):109-18. PubMed ID: 10512168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea induced perimalleolar ulcers.
    Saravu K; Velappan P; Lakshmi N; Shastry BA; Thomas J
    J Korean Med Sci; 2006 Feb; 21(1):177-9. PubMed ID: 16479088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphan.
    Nielsen I; Hasselbalch HC
    Am J Hematol; 2003 Sep; 74(1):26-31. PubMed ID: 12949887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Painful leg ulcers and a rash in a patient with polycythaemia rubra vera. Diagnosis: hydroxyurea-induced leg ulceration and dermatomyositis-like skin changes.
    Haniffa MA; Speight EL
    Clin Exp Dermatol; 2006 Sep; 31(5):733-4. PubMed ID: 16901329
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders.
    Randi ML; Ruzzon E; Luzzatto G; Tezza F; Girolami A; Fabris F
    Haematologica; 2005 Feb; 90(2):261-2. PubMed ID: 15710584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leg ulcers in patients with myeloproliferative disorders: disease- or treatment-related?
    Bader U; Banyai M; Böni R; Burg G; Hafner J
    Dermatology; 2000; 200(1):45-8. PubMed ID: 10681614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hydroxyurea induced-leg ulcer in polycythemia vera].
    Khaled A; El Guellali N; Aissaoui L; Robbana F; Ezzine N; Fazaa B; Kamoun MR
    Tunis Med; 2011 Mar; 89(3):292-4. PubMed ID: 21387237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hydroxyurea-induced pneumonitis].
    Schwonzen M; Spangenberger H; Spengler M
    Med Klin (Munich); 2003 Jul; 98(7):394-7. PubMed ID: 12937905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea induced dermatomyositis-like eruption.
    Zappala TM; Rodins K; Muir J
    Australas J Dermatol; 2012 Aug; 53(3):e58-60. PubMed ID: 22881475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea-induced melanonychia concomitant with a dermatomyositis-like eruption.
    Oh ST; Lee DW; Lee JY; Cho BK
    J Am Acad Dermatol; 2003 Aug; 49(2):339-41. PubMed ID: 12894095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudo-dermatomyositis as a complication of hydroxyurea therapy.
    Marie I; Joly P; Levesque H; Heron F; Courville P; Cailleux N; Courtois H
    Clin Exp Rheumatol; 2000; 18(4):536-7. PubMed ID: 10949738
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous ulcerations on hands and heels secondary to long-term hydroxyurea treatment.
    Friedrich S; Raff K; Landthaler M; Karrer S
    Eur J Dermatol; 2004; 14(5):343-6. PubMed ID: 15358575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyurea-induced interstitial pneumonitis: case report and review of the literature.
    Internullo M; Giannelli V; Sardo L; Antonaglia C; Villani T; Angelici E; Palange P
    Eur Rev Med Pharmacol Sci; 2014; 18(2):190-3. PubMed ID: 24488907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.